A Phase I Study of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion

Summary

A Phase I, Open, Multicenter Clinical Study to Evaluate the Safety, Tolerance, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of JMKX000197 Injection in the Treatment of Malignant Pleural Effusion

Timeline

Start

2023-05-22

Primary completion

2025-04-30

Completion

2025-05-01

Drugs

Indications